Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanara MedTech is a medical technology company focused on developing and commercializing transformative solutions for the surgical and chronic wound care markets. The company's flagship product line, CellerateRX, utilizes activated collagen to promote healing in various wound types, including surgical, traumatic, and chronic wounds. Sanara also offers a range of other products such as debridement tools, skin substitutes, and bone grafting materials. Their business model emphasizes providing high-quality, cost-effective clinical solutions to improve patient outcomes in acute and post-acute care settings. The company is headquartered in Fort Worth, Texas, and is publicly traded on the NASDAQ under the symbol SMTI.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanara Collagen Peptides.